Quick Answer
ALBEMARLE CORP reported Total Revenue of $5.14 billion for fiscal year 2025.
ALBEMARLE CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.14B -4.4% |
$5.38B -44.1% |
$9.62B +31.4% |
$7.32B +120.0% |
$3.33B +6.4% |
$3.13B -12.8% |
| Net Income | -$510.63M +56.7% |
-$1.18B -175.0% |
$1.57B -41.5% |
$2.69B +2075.0% |
$123.67M -67.1% |
$375.76M -29.5% |
| Diluted EPS | -$5.76 +48.6% |
-$11.20 -183.8% |
$13.36 -41.5% |
$22.84 +2054.7% |
$1.06 -69.9% |
$3.52 -29.9% |
| Total Assets | $16.37B -1.4% |
$16.61B -9.1% |
$18.27B +18.2% |
$15.46B +40.8% |
$10.97B +5.0% |
$10.45B +6.0% |
| Cash and Equivalents | — | — | — | — | — | — |
| Long-Term Debt | $3.12B +0.0% |
$3.12B -11.9% |
$3.54B +10.1% |
$3.21B +60.4% |
$2.00B -27.6% |
$2.77B -3.3% |
| Stockholders Equity | $9.53B -4.3% |
$9.96B +5.8% |
$9.41B +17.9% |
$7.98B +41.9% |
$5.63B +31.8% |
$4.27B +8.5% |
| R&D Expense | $51.40M -40.7% |
$86.72M +1.2% |
$85.72M +19.1% |
$71.98M +33.2% |
$54.03M -8.8% |
$59.21M +1.6% |
| Operating Income | -$367.08M +79.3% |
-$1.78B -805.3% |
$251.88M -89.8% |
$2.47B +209.4% |
$798.43M +57.9% |
$505.81M -24.1% |
| Gross Profit | $668.72M +969.3% |
$62.54M -94.7% |
$1.19B -61.4% |
$3.07B +208.1% |
$997.97M +0.3% |
$994.85M -20.9% |
| Shares Outstanding | 117.72M +0.1% |
117.56M +0.2% |
117.36M +0.2% |
117.17M +0.1% |
117.02M +9.5% |
106.84M +0.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.31B | -3.5% | -1.7% |
| Net Income | September 30, 2025 | -$160.69M | +85.0% | -801.8% |
| Diluted EPS | September 30, 2025 | -$1.72 | +81.8% | -975.0% |
| Total Assets | September 30, 2025 | $17.15B | -1.8% | -0.8% |
| Cash and Equivalents | September 30, 2025 | $1.93B | +16.1% | +6.9% |
| Long-Term Debt | September 30, 2025 | $3.18B | -10.8% | +0.1% |
| Stockholders Equity | September 30, 2025 | $10.00B | -2.4% | -2.4% |
| R&D Expense | September 30, 2025 | $12.67M | -43.4% | +1.8% |
| Operating Income | September 30, 2025 | -$216.99M | +80.4% | -556.6% |
| Gross Profit | September 30, 2025 | $117.61M | +213.0% | -40.3% |
| Shares Outstanding | September 30, 2025 | 117.69M | +0.1% | +0.0% |
- ALBEMARLE CORP reported Total Revenue of $5.14 billion for fiscal year 2025.
- ALBEMARLE CORP showed a decrease of -4.4% in Total Revenue compared to the prior fiscal year.
- ALBEMARLE CORP reported Net Income of -$510.63 million for fiscal year 2025.
- ALBEMARLE CORP showed an increase of +56.7% in Net Income compared to the prior fiscal year.
- ALBEMARLE CORP reported Diluted EPS of $5.76 per share (loss) for fiscal year 2025.
- ALBEMARLE CORP showed an increase of +48.6% in Diluted EPS compared to the prior fiscal year.
- ALBEMARLE CORP reported Total Assets of $16.37 billion for fiscal year 2025.
- ALBEMARLE CORP showed a decrease of -1.4% in Total Assets compared to the prior fiscal year.
- ALBEMARLE CORP reported Cash and Equivalents of $613.11 million for fiscal year 2019.
- ALBEMARLE CORP showed an increase of +10.4% in Cash and Equivalents compared to the prior fiscal year.
- ALBEMARLE CORP reported Long-Term Debt of $3.12 billion for fiscal year 2025.
- ALBEMARLE CORP showed an increase of +0.0% in Long-Term Debt compared to the prior fiscal year.
- ALBEMARLE CORP reported Stockholders Equity of $9.53 billion for fiscal year 2025.
- ALBEMARLE CORP showed a decrease of -4.3% in Stockholders Equity compared to the prior fiscal year.
- ALBEMARLE CORP reported R&D Expense of $51.40 million for fiscal year 2025.
- ALBEMARLE CORP showed a decrease of -40.7% in R&D Expense compared to the prior fiscal year.
- ALBEMARLE CORP reported Operating Income of -$367.08 million for fiscal year 2025.
- ALBEMARLE CORP showed an increase of +79.3% in Operating Income compared to the prior fiscal year.
- ALBEMARLE CORP reported Gross Profit of $668.72 million for fiscal year 2025.
- ALBEMARLE CORP showed an increase of +969.3% in Gross Profit compared to the prior fiscal year.
- ALBEMARLE CORP reported Shares Outstanding of 117.72 million shares for fiscal year 2025.
- ALBEMARLE CORP showed an increase of +0.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: